Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets
Advanced Science · 2026
DOI: 10.1002/advs.202508870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Huixiao Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology and Metabolism, Shandong …. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, Genetic Therapy, Fibroblast Growth Factors, DNA, Circular. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Major Science and Technology Projects of China, Academic promotion program of Shandong First Medical University.
Abstract (Originalsprache)
X‐linked hypophosphatemic rickets (XLHR) is a rare X‐linked dominant skeletal dysplasia caused by phosphate regulating endopeptidase homolog X‐linked (PHEX) gene mutation. Until now, the pathogenic role of PHEX has not been fully determined, and there has been no radical cure for XLHR. In the previous study, a novel PHEX variant (c.T1349C; p.L450P) is identified in a child with XLHR. The present study aims to reveal its pathogenic role and evaluate the therapeutic effects of the minicircle (MC)‐DNA in XLHR. In vitro, the wildtype and mutant plasmids are introduced into HEK293 cells. In vivo, a new knock‐in XLHR mouse model carrying the novel variant is established. Furthermore, this study makes the first attempt to perform gene therapy using a MC‐DNA vector expressing a fragment of FGF23 (amino acids 180‐251) in the Phex ‐T1349C mice. The new mouse model demonstrates the clinical manifestations of XLHR seen in the patient, including a gene dosage effect. Furthermore, MC‐DNA is found to slightly increase blood phosphorus levels, significantly decrease serum alkaline phosphatase levels, and improve bone mineralization without apparent adverse effects for at least 6 weeks. This study suggests MC‐DNA as a promisingly safe and effective therapeutic strategy to treat XLHR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University, J…
- Shandong Provincial Research Center for Stem Cells and Gene Therapy of Endocrine Metabolic Diseases, Jinan, 250021, P. R. China.
- Institute of Endocrinology, Shandong Academy of Clinical Medicine, Jinan, 250021, P. R. China.
- Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, 250021, P. R. China.
- Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, P. R. China.
- Department of Radiology, Shandong Rongjun General Hospital, Jinan, 250013, P. R. China.
ORCID-Profile: Chao Xu
Förderung
- National Natural Science Foundation of China
- National Major Science and Technology Projects of China
- Academic promotion program of Shandong First Medical University
- Taishan Scholar Project
Zitieren
APA
Wu, H., Zhao, W., Chen, X., Wang, Y., Wei, S., Xiang, B., Shi, Y., Li, Z., Yao, Y., Xie, J., Qiu, R., Shu, M., Xu, S., Chen, P., Chen, Z., Wu, Y., Xia, W., Gao, L., Song, Y., …, & Xu, C. (2026). Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets. Advanced Science. https://doi.org/10.1002/advs.202508870
Vancouver
Wu H, Zhao W, Chen X, Wang Y, Wei S, Xiang B, et al. Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets. Advanced Science. 2026. doi:10.1002/advs.202508870
BibTeX
@article{Wu2026,
author = {Wu, Huixiao and Zhao, Wanyi and Chen, Xinyu and Wang, Yanzhou and Wei, Shuoshuo and Xiang, Bo and Shi, Yingzhou and Li, Zongyue and Yao, Yangyang and Xie, Jin and Qiu, Renyuan and Shu, Meng and Xu, Shuo and Chen, Ping and Chen, Zhiying and Wu, Yingjie and Xia, Weibo and Gao, Ling and Song, Yongfeng and Zhao, Jiajun and Xu, Chao},
title = {Treatment with Minicircle DNA Expressing a FGF23 Fragment in a Clinically relevant Mouse Model of X‐Linked Hypophosphatemic Rickets},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202508870}
}
EUVIMED